Sale!

SLU-PP-332 — 500mcg | Research Use Only (RUO)

Original price was: $149.99.Current price is: $125.00.

SLU-PP-332 (500mcg) capsule. Synthetic ERR agonist compound for laboratory research applications. Purity ≥98%. Certificate of Analysis available.

28 in stock

SKU: RES-SLUPP-500 Category:

Description

A synthetic small-molecule compound currently being investigated in controlled laboratory environments for its interaction with estrogen-related receptor (ERR) signaling pathways and metabolic transcription factors.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

SLU-PP-332 is a synthetic agonist studied in preclinical models for its interaction with the estrogen-related receptor (ERR) family of nuclear receptors. Laboratory research has examined its role in transcriptional regulation, metabolic gene expression, and mitochondrial-related signaling pathways under controlled experimental conditions. It is classified as a small-molecule research compound rather than a peptide.

Supplied as a capsule for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: SLU-PP-332
Quantity: 500 mcg per capsule
Form: Capsule
Purity: ≥98%
Storage: Room temperature, protect from moisture and light

RESEARCH APPLICATIONS

– Estrogen-related receptor agonist studies
– Nuclear receptor transcriptional regulation research
– Metabolic gene expression pathway analysis
– Mitochondrial signaling and biogenesis modeling

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.

Additional information

Weight 0.1 lbs
size

30mg

Reviews

There are no reviews yet.

Be the first to review “SLU-PP-332 — 500mcg | Research Use Only (RUO)”

Your email address will not be published. Required fields are marked *